NAFDAC recalls BP medicine linked to cancer

The National Agency for Food and Drug Administration and Control (NAFDAC) has joined other regulatory agencies worldwide to recall a blood pressure medication from the market after it was found to contain a cancer-causing chemical.

Valsartan, made in China, was recalled in 22 countries, including the United Kingdom (UK) and the United States (U.S.) earlier in July, but the warning is now worldwide.

Investigators found that N-Nitrosodimethylamine, a chemical used in rocket fuel, had contaminated the drug’s production at Zhejiang Huahai, a Chinese company that ships the medicine worldwide.

Director-General of NAFDAC, Prof. Moji Adeyeye, told The Guardian yesterday: “We have ordered a recall of the product and raised caution on its use due to contamination”.

The Guardian, August 2, 2018

 

RipplesNigeria… without borders, without fears

Click here to join the Ripples Nigeria WhatsApp group for latest updates.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now